121
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Cutaneous Macroglobulinosis Presenting as Serpiginous Purpura, a Case Report and Literature Review

, ORCID Icon, ORCID Icon, &
Pages 1057-1064 | Published online: 26 Aug 2021

References

  • Yun S, Johnson AC, Okolo ON, et al. Waldenström Macroglobulinemia: review of pathogenesis and management. Clin Lymphoma Myeloma Leuk. 2017;17(5):252–262. doi:10.1016/j.clml.2017.02.028
  • Vijay A, Gertz MA. Waldenström macroglobulinemia. Blood. 2007;109(12):5096–5103. doi:10.1182/blood-2006-11-055012
  • Libow LF, Mawhinney JP, Bessinger GT. Cutaneous Waldenström’s macroglobulinemia: report of a case and overview of the spectrum of cutaneous disease. J Am Acad Dermatol. 2001;45(6 Suppl):S202–6. doi:10.1067/mjd.2001.103262
  • Hassab-El-Naby HMM, El-Khalawany M, Rageh MA. Cutaneous macroglobulinosis with Waldenström macroglobulinemia. JAAD Case Rep. 2020;6(8):771–775. doi:10.1016/j.jdcr.2020.06.024
  • Stien S, Durot E, Durlach A, et al. Cutaneous involvement in Waldenström’s macroglobulinaemia. Acta Derm Venereol. 2020;100(15):adv00225. doi:10.2340/00015555-3535
  • Tichenor RE, Rau JM, Mantz FA. Macroglobulinemia cutis. Arch Dermatol. 1978;114(2):280–281. doi:10.1001/archderm.1978.01640140090024
  • Cobb MW, Domloge-Hultsch N, Frame JN, Yancey KB. Waldenström macroglobulinemia with an IgM-kappa antiepidermal basement membrane zone antibody. Arch Dermatol. 1992;128(3):372–376. doi:10.1001/archderm.1992.01680130086011
  • Oshio-Yoshii A, Fujimoto N, Shiba Y, et al. Cutaneous macroglobulinosis: successful treatment with rituximab. J Eur Acad Dermatol Venereol. 2017;31(1):e30–e31. doi:10.1111/jdv.13613
  • Camp BJ, Magro CM. Cutaneous macroglobulinosis: a case series. J Cutan Pathol. 2012;39(10):962–970. PMID: 22882527. doi:10.1111/j.1600-0560.2012.01983.x
  • Gressier L, Hotz C, Lelievre JD, et al. Cutaneous macroglobulinosis: a report of 2 cases. Arch Dermatol. 2010;146(2):165–169. doi:10.1001/archdermatol.2009.359
  • Bernstein LE, Shea CR, Baron JM. Erythematous papules on the legs. IgM storage papules in association with Waldenstrom macroglobulinemia. Arch Dermatol. 2009;145:77.
  • Mascaro JM, Montserrat E, Estrach T, et al. Specific cutaneous manifestations of Waldenström’s macroglobulinaemia: a report of two cases. Br J Dermatol. 1982;106(2):217–222. doi:10.1111/j.1365-2133.1982.tb00932.x
  • Harnalikar M, Pande S, Kharkar V, Khopkar U. Keratotic vascular papules over the feet: a case of Waldenström’s macroglobulinaemia-associated cutaneous macroglobulinosis. Clin Exp Dermatol. 2010;35(3):278–281. doi:10.1111/j.1365-2230.2009.03651.x
  • Lüftl M, Sauter-Jenne B, Gramatzki M, Eckert F, Jenne L. Cutaneous macroglobulinosis deposits in a patient with IgM paraproteinemia/incipient Waldenström macroglobulinemia. J Dtsch Dermatol Ges. 2010;8(12):1000–1003.
  • Marchand T, Tas P, Houot R, et al. Cutaneous macroglobulinosis treated with bortezomib and rituximab. Eur J Haematol. 2011;87(1):98. doi:10.1111/j.1600-0609.2011.01610.x
  • D’Acunto C, Nigrisoli E, Liardo EV, et al. Painful plantar nodules: a specific manifestation of cutaneous macroglobulinosis. J Am Acad Dermatol. 2014;71(6):e251–e252. doi:10.1016/j.jaad.2014.08.041
  • Roupie AL, Battistella M, Talbot A, et al. Coexisting cutaneous macroglobulinosis and scleredema of Buschke in a patient with a Waldenstrom macroglobulinemia. J Eur Acad Dermatol Venereol. 2019;33(3):e104–e106. doi:10.1111/jdv.15268
  • Fayne R, Rosenberg M, White K, et al. Disseminated cutaneous immunoglobulin M macroglobulinosis associated with cryoglobulinemia and minimal residual disease of Waldenstrom macroglobulinemia. JAAD Case Rep. 2019;5(10):918–922. doi:10.1016/j.jdcr.2019.06.037